Body Weight

An oral chemotherapy treatment used to treat myeloproliferative neoplasms is associated with substantial weight gain and increased systolic blood pressure, according to findings from a real-world analysis published in Scientific Reports.

Oral semaglutide was shown to be superior to placebo for lowering HbA1c and body weight among adults with type 2 diabetes already taking insulin with or without metformin, according to findings published in Diabetes Care.

Body fat mass — but not nonfat mass — was a causal risk factor for depression, indicating that fat drives the observed BMI-depression causality, according to data from a Mendelian randomization study.

HOUSTON — In this video exclusive, Asha Brown, founder and executive director of We Are Diabetes, speaks with Endocrine Today Diabetes in Real Life columnist Susan Weiner, MS, RDN, CDE, FAADE, about eating disorders and how they manifest among people with type 1 diabetes.

ORLANDO — As the obesity epidemic continues to grow in the United States, it is critical that health care providers confront patient misconceptions about the causes of obesity and how the surplus of “nutritionally-bankrupt food” has contributed to a rise in such chronic diseases, according to a presentation at the Rheumatology Nurses Society Annual Conference.

A recent cohort study identified an increasing incidence of colorectal cancer diagnoses among Canadian men and women younger than 50 years.